Noteless AS

Based in Norway, Noteless AS provides an AI-driven medical note-taking solution that enhances healthcare professionals' efficiency by streamlining the documentation process during patient consultations. Founded in 2023 in Oslo, Norway, Noteless AS specializes in developing innovative note-taking technology for healthcare practitioners. The company has completed a total of 2 deals, including a Seed funding round where it raised EUR 3. 50 mn led by Redstone, with participation from Farvatn Venture and Futurum Ventures.

Noteless is independently operated without any disclosed parent or subsidiary relationships. Noteless offers an AI-driven medical note-taking solution designed specifically for healthcare professionals, aimed at improving workflow and reducing administrative burdens. Users can activate their microphone within the Noteless application to document patient consultations effortlessly, as the software captures and formats relevant medical insights into structured clinical notes. This solution caters to various healthcare providers, including general practitioners, physiotherapists, and specialists, allowing for personalized notes through customizable phrases and documentation layouts.

Noteless serves clients across multiple markets, including Norway, Denmark, and the Netherlands. Noteless operates on a subscription-based revenue model that gives healthcare professionals access to its advanced note-taking features. Clients subscribe for a defined period to utilize the platform for creating AI-assisted clinical notes, ultimately saving time and alleviating stress. The subscription structure is designed to foster ongoing relationships with users, who receive continuous updates and support.

Although specific pricing details are not available, the model accommodates different tiers based on usage and features, catering to both individual practitioners and larger healthcare organizations. Noteless AS plans to leverage its recent funding to enhance its product offerings and expand into new markets. The company is focused on developing additional features and products to further assist healthcare providers, though specific release dates are not mentioned. The funding from new investors will support these initiatives while targeting broader geographic expansion beyond its current presence in Norway, Denmark, and the Netherlands.